| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8222929 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 7 Pages |
Abstract
The addition of TMZ or ETN to WBRT + SRS in NSCLC patients with 1 to 3 brain metastases did not improve survival and possibly had a deleterious effect. Because the analysis is underpowered, these data suggest but do not prove that increased toxicity was the cause of inferior survival in the drug arms.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Paul W. MD, MPP, Meihua PhD, H. Ian MD, PhD, Michael C. PhD, Maria MD, Ritsuko MD, Luis MD, Mark K. MD, Deepak MD, William MD, Sunjay A. MD, Lucien A. MD, Gad MD, John H. MD, Minesh P. MD,